UnitedHealth Group Inc. (UNH) Set to Announce Earnings on Tuesday
UnitedHealth Group Inc. (NYSE:UNH) will be posting its Q316 quarterly earnings results on Tuesday, October 18th. Analysts expect UnitedHealth Group to post earnings of $2.08 per share and revenue of $46.11 billion for the quarter.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm had revenue of $46.50 billion for the quarter, compared to the consensus estimate of $45.05 billion. On average, analysts expect UnitedHealth Group to post $7.90 EPS for the current fiscal year and $9.07 EPS for the next fiscal year.
Shares of UnitedHealth Group Inc. (NYSE:UNH) opened at 134.19 on Friday. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48. The company has a market capitalization of $127.80 billion, a P/E ratio of 21.00 and a beta of 0.57. The stock has a 50 day moving average of $137.12 and a 200-day moving average of $136.48.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.65% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Van Hulzen Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $104,000. Eubel Brady & Suttman Asset Management Inc. acquired a new position in UnitedHealth Group during the second quarter valued at approximately $209,000. Bellwether Investment Group LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $220,000. Ancora Advisors LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $238,000. Finally, MCF Advisors LLC raised its position in UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock valued at $243,000 after buying an additional 763 shares during the last quarter. 85.78% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently commented on UNH. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $161.00 price objective (up from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Barclays PLC upped their price objective on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a report on Wednesday, July 20th. Citigroup Inc. upped their price objective on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective on the stock in a report on Friday, July 22nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $155.35.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.